Syncom Formulations (India) Ltd: A Smallcap Pharma Company Making Waves in Stock Market
Syncom Formulations (India) Ltd, a smallcap pharmaceutical company, has been making headlines in the stock market with its recent performance. On September 6, 2024, the company's stock price reached an all-time high of Rs. 23.07, outperforming its sector by 3.13%. With a 170.29% growth in the past year, the company shows strong financials and potential for further growth.
Syncom Formulations (India) Ltd, a smallcap pharmaceutical company, has been making waves in the stock market with its recent performance. On September 6, 2024, the company's stock price reached an all-time high of Rs. 23.07, marking a significant milestone for the company.
MarketsMOJO, a leading stock market analysis and recommendation platform, has given a 'Buy' call for Syncom Formulations (India) Ltd. This is a testament to the company's strong performance and potential for growth in the future.
In terms of price performance, Syncom Formulations (India) Ltd has outperformed its sector by 3.13% and has been on a consecutive gain for the past 3 days, with a 15.17% increase in its stock price. The company's stock is also trading higher than its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a positive trend.
In the past year, Syncom Formulations (India) Ltd has shown an impressive growth of 170.29%, outperforming the Sensex's performance of 24.50%. This showcases the company's strong financials and potential for further growth in the future.
With its consistent performance and positive outlook, Syncom Formulations (India) Ltd is definitely a stock to watch out for in the pharma industry. Investors can consider adding this smallcap company to their portfolio for potential long-term gains.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
